The LYNX Dissolution Test Apparatus is designed to evaluate the dissolution of pharmaceutical dosage forms under controlled testing conditions. It helps determine the rate at which active ingredients are released from tablets and capsules into a specified dissolution medium. Suitable for pharmaceutical laboratories, research facilities, and quality control departments, the apparatus supports routine dissolution testing for evaluating the performance and quality of solid oral dosage forms.

Parameter	Details
Product Type	Dissolution Test Apparatus
Primary Function	Pharmaceutical Dissolution Testing
Sample Type	Tablets and Capsules
Testing Purpose	Evaluation of Drug Release
Application Areas	Pharmaceutical Laboratories, Research, and Quality Control